뇌질환의 혁신, 뉴로벤티(NeuroVenti)

NEWS

Here's the news about NeuroVenti

News/Notice

K-BD Group, held the 2nd Pharma & Bio Business Development Strategy Fo…

페이지 정보

조회 1,207회 작성일 21-11-03

본문

K-BD Group, held the 2nd Pharma & Bio Business Development Strategy Forum

21-11-03


Topic of 'Strategies for Coexistence and Cooperation with Bio Startups to Strengthen Global Innovation Competitiveness in the Bio-Health Industry'


The Korea Drug Development Research Association (Chairman Kim Dong-yeon, hereinafter referred to as the New Drug Association) is a pharmaceutical and bio business development research group (Research Chairman Lee Jae-hyun, hereinafter K-BD Group), a group of domestic industry, academia, research, venture and startup business development experts. It was announced that the '2021 2nd Pharmaceutical and Bio Business Development Strategy Forum' was successfully held at COEX, Seoul on November 3 (Wednesday).

 

The business development strategy forum, co-hosted by the New Drug Association and the Hongneung Jiangsu Special Zone Project Group, was held under the theme of "Strategies for Win-Win Cooperation with Bio Startups to Strengthen Global Innovation Competitiveness in the Bio Health Industry."

In particular, it is their position that by preparing a venue for sharing information on the overall necessary for strategic open innovation with bio-startups, they identified global trends and presented essential action plans in the entire process from the establishment of bio-startups to the execution of exit strategies.

 

About 170 people from industry, academia, research, government, and universities in the domestic bio-health industry attended and received a great response.

The forum began with a greeting from Jaehyun Lee, Research Chairman of K-BD Group, ▲Identification of global technology trends of major pharmaceutical and bio products using bioinformatics (Consultant Hyojin Park, Clarivate) ▲Startup process and successful exit strategy (Co., Ltd.) Shim Kyung-sik, CEO of SYP) ▲Strategic partnership strategy with pharmaceutical and biotech start-ups (Ildong Pharmaceutical Co., Ltd. Seo Jin-sik) ▲Bio-startup growth strategy (CEO Shin Chan-young, Neuroventi Co., Ltd.) were announced.

 

▲ Domestic venture capital investment strategies for bio-startups (Daily Partners Co., Ltd. Park In-ae) ▲ Bio-startup technology evaluation (Korea Invention Promotion Association, Manager Koh Ki-young) ▲ Domestic and foreign bio-startup incubation status and prospects (Director Choi Chi-ho, Korea Institute of Science and Technology) ▲ A total of eight topics were presented by experts in each field, such as start-up entrepreneurship and support system (Expert Committee member Lee Kyung, Institute of Startup & Entrepreneurship Promotion).

 

In addition, on November 4, the New Drug Association and the Hongneung Jiangsu Special Zone Project Group jointly held the 'K-BD Group 2021 2nd Promising Bio Venture Startup Investment Forum' at the same place to promote biotechnology that possesses promising technologies. IR presentations will be held with 15 startup companies participating.

Subsequently, 10 companies announced IRs through the '2021 R&D-centered Excellent Pharmaceutical and Bio Company IR (IPIR 2012)' held by the K-BD Group, discovering promising ventures and start-ups and investing and cooperation between investment institutions and pharmaceutical and bio companies We plan to provide a venue for seeking activation of links, etc.

 

Meanwhile, the New Drug Association also sponsored and held the 'KOREA LIFE SCIENCE WEEK 2021', a premium exhibition and conference event in the domestic life science field, and in connection with this, pharmaceutical and bio companies, bio ventures and start-ups owned The 'KDRA Bio Innovation Company Joint Public Relations Center' and the 'KDRA Bio Health Partnering & Poster Zone' are operated to actively publicize the excellent technologies available to domestic and foreign companies and investment institutions.

 

'KDRA Bio Innovation Company Joint Public Relations Center' and 'KDRA Bio Health Partnering & Poster Zone' are held at COEX 1st floor B Hall, Seoul until November 4th. Logics Co., Ltd., Trial Informatics Co., Ltd., Invivotech Co., Ltd., Well Marker Bio Co., Ltd., Helixmith Co., Ltd., Medicine Park Co., Ltd., Seongi Bio Co., Ltd., Time Bio Co., Ltd., Owl Bio Co., Ltd., Inno Pharma Screen Co., Ltd., Hongreung Jiangsu Special Zone Project Group, Korea Nuclear Power Pharmaceutical and bio companies such as medical institutes, bio ventures, start-up companies, and research institutes participate.

List
NeuroVenti, Inc. 4th FL, 15, Seolleung-ro 121-gil, Gangnam-gu, Seoul, Republic of Korea
TEL : 82-2-540-5630 FAX : 82-2-548-5630 E-mail : contact@neuroventi.com

Copyright © 2024 뇌질환의 혁신, 뉴로벤티(NeuroVenti). All Rights Reserved.

Business registration number: 181-86-00128, Representative: Chan Young Shin, Dong-chul Seo

Privacy Policy

×
'NeuroVenti' ("Company") places great importance on customers' personal information and wants to let customers know that it complies with the personal information protection regulations in the relevant law such as Personal Information Protection Act, Telecommunications Business Act, Protection of Communications Secrets Act based on Korean laws as well as how and for what purpose the personal information provided by customers is used and what measures are being taken to protect personal information through Company's policy on personal information handling

1. Personal lnformation Items to be Collected
Company collects and stores minimum and necessary information for providing its services to the member. The described information is collected in the following situations below.

- Information: Name, e-mail address, phone number
- collection method : Web site

2. Personal lnformation Collection and lts Purpose
Company collects personal information for the following purpose, and all personal information will only be collected with your consent.
-To make inquiries and responses in respect of contract execution and service provision.

3. Retention of Personal lnformation and Period of Its Use
After collecting personal information and achieving the purpose of its use, without exceptions, Company destroys the information immediately. For the following information only, however, Company retains them for the indicated period for the following reasons
- When the answer was completed

4. Provision of Personal Information
In principle, Company does not provide the personal information of users to the outside except in cases where the user has consent or is subject to the provisions of relevant laws and regulations. Note, however, that the following cases are exceptions.
- When the user agreed in advance
- When delivering sample collection kit
* Name of delivery service company: Fedex, UPS, DHL, etc
-If there is a request in accordance with the provisions of the law or the procedure and method prescribed by the law for the purpose of investigation
-If it is necessary for statistics, academic research, or market research and only when if it is provided in a form that cannot be identified

5. Destruction Process and Method of Personal Information
In principle, after collecting personal information and achieving the purpose of its use, Company destroys the information immediately without exceptions. The destruction process and method are as follows
1) Destruction Process
The information inputted by the user for membership, etc, shall be moved to a separate DB (in case of paper, separate document file) after the purpose of its use is achieved. It shall be destroyed after being retained for a certain period according to Company's internal policy and the reason for information protection based on the relevant laws (refer to Retention of Personal lnformation and Period of its Use")
2) Destruction Method Personal information printed out in paper shall be shredded by the shredder or incinerated. Personal information saved in electronic file form shall be deleted by a technical method that renders the records irreproducible.

6. Technical/Managerial Protection Measure for Personal Information
Company considers the following technical/managerial measures for securing safety to prevent loss, theft, leak, falsification or damage when handling personal information

7. Regarding the Installation, Operation, and Refusal of Automatic Collection Device of Personal Information
Company operates "cookies," which frequently save and find the information of the user. A cookie is a small text file sent by the server operating the website to the browser of the user and is saved on hard disk. Company uses cookies for the following purposes
A. Purpose of Use of Cookies
- In order to provide personalized services on your next visit, Company tracks the information on the web pages that you visit and browse with interest
- Cookies are used as resources to provide differentiated opportunities for participating in Company's events based onyour number of visits and to provide differentiated information according to individual interests.
The user has a choice with regard to cookie installation on the website he/she visited. Therefore, the user can permit cookies, check and confirm whenever cookies are saved, or refuse to save cookies by setting the option on the web browser.
B. Setting Method of Cookie (Permit/Refuse
The user can permit cookies, check and confirm whenever a cookies are saved, or refuse to save cookies by setting the option in the web browser.
Example of Setting Method (in the case of Internet Explorer) : Tool in the upper part of the web browser >Internet Options >Personal Information Tab >Setting the Personal information Handling Level When the user refuses cookie installation, providing services requiring login may be difficult.

8. Customer Complaint Handling Service Regarding Personal Information
Company has designated the following department and person in charge of personal information management to protect the personal information of customers and to handle complaints regarding personal information.
You may report all complaints related to personal information from your use of our services to the personal information management manager or department. Company will respond promptly and adequately to your complaints. If you need to report or consult about other privacy infringement, please contact the following organizations.

- Korean internet & Security Agency (privacy.kisa.or.kr / +82-2-405-5118)
- ePRIVACY (www.eprivacy.or.kr / +82-2-580-0533 ~ 4)
- Supreme Prosecutors' Office (www.spo.go.kr / +82-2-3480-2000)
- Korean National Police Agency Cyber Bureau (cyberbureau.police.go.kr / +82-2-392-0330)

I agree to the privacy policy.

이용안내

×
내용이 나옵니다.